3 completed. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Limited Stage Small Cell Lung Carcinoma: new trials by email Literature Review of Limited Stage Small Cell Lung Carcinoma trials Research Report on Limited Stage Small Cell Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer Best Practice, Laboratory Biomarker Analysis, Supportive Care - Acute Myeloid Leukemia, Brain Glioblastoma | Not applicable | Completed | Stanford University | 128 | 2017-08-08 | 2025-01-24 |
| Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy - Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 418 | 2015-12-22 | 2026-07-10 |
| Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer Carboplatin, Cisplatin, Etoposide - Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 83 | 2015-07-22 | 2026-03-10 |
Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Disease Progression (1) · Esophageal Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Melanoma (1) · Myelodysplastic Syndromes (1) · Neuroendocrine Tumors (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Recurrence (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Adenocarcinoma (1) · Adnexal Diseases (1) · Bone Diseases (1) · Bone Marrow Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Colorectal Neoplasms (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Palliative Care (1) · Platinum (1) · Practice Guidelines as Topic (1) · Radiation (1) · Radiotherapy (1) · Radiotherapy, Conformal (1) · Radiotherapy, Intensity-Modulated (1) · Standard of Care (1) · pembrolizumab (1)
M.D. Anderson Cancer Center (1) · NRG Oncology (1) · Stanford University (1)
United States (3) · Canada (1)
James Welsh (1) · Manali Patel (1) · Vinai Gondi (1)
PMID 31605794, PMID 34632876, PMID 34749008, PMID 35771552, PMID 40789106
P30CA016672 (1), UG1CA189867 (1)